Therabron

A privately held #biotech company developing a new class of drugs using secretoglobin proteins in an effort to transform the management of respiratory diseases.

[Therabron @Therabron]

It’s #rare #lung #disease week at the @atscommunity. Check out their website for more information: https://t.co/Z0UsimopZ4

[Therabron @Therabron]

.@Therabron receives @US_FDA Rare Pediatric Disease Designation for rhCC10, Co's lead Ph2 program in preterm infants https://t.co/YSvknVlqyV

[Therabron @Therabron]

President and CEO Thomas Miller of @Therabron announced today that he will present at the #BIO2016 on 6/7 in SF. https://t.co/Iwg6cUkEke

[Therabron @Therabron]

.@Therabron President/CEO, Thomas Miller, will present a corporate overview/update at #Jefferies HC Conf. on 6/9. https://t.co/t0PsdMSkBZ

[Therabron @Therabron]

.@Therabron announced it completed enrollment of its Ph2 trial for prevention of neonatal CRM in #prematurebabies. https://t.co/cp9f9oExMq

[Therabron @Therabron]

.@Therabron appoints 4 world-renowned pulmonary experts to their Scientific Advisory Board. #respiratory https://t.co/6enNQc71lM

[Therabron @Therabron]

.@Therabron will be presenting new recombinant secretoglobin data at #ATS2016, May 13-18, in San Francisco. https://t.co/uTTs0SvR9n

[Therabron @Therabron]

.@Therabron receives @FDA Fast Track Designation for chronic lung disease drug, rhCC10, in neonates #biotech https://t.co/2Ba4QxSaoE

[Therabron @Therabron]

.@Therabron CEO Dr. Tom Miller to Present at World Orphan Drug Congress 2016, April 21 in Washington, D.C. #WODC2016 https://t.co/tiN2Wtd5wg

[Therabron @Therabron]

Therabron Therapeutics Receives Notice of Allowance for Patent Supporting the Recombinant CC10 Technology Platform - https://t.co/EJ2MBhVrmx

[Therabron @Therabron]

We're pleased to announce former $PIP CEO & $MEDI founding team member, Eric Richman to our board of directors. https://t.co/H8YZimaCHl

[Therabron @Therabron]

(3/3) Ms. Linda Change has joined Therabron as SVP and CFO https://t.co/3FbF5pmdom #biotech #pharma

[Therabron @Therabron]

(2/3) Dr. Alan Cohan has joined Therabron as SVP and CMO https://t.co/Vqt47ynmZE #biotech #pharma

[Therabron @Therabron]

Company announces expansion of senior management team https://t.co/Pk6nPG9Z0R #biotech #pharma (1/3)

[Therabron @Therabron]

Company announces new study aimed to create multiple novel isoforms of lead candidate, rhCC10 #biotech #pharma https://t.co/lCbkYCPJeN

[Therabron @Therabron]

Support #RareDiseaseDay & submit a Handprints Across America photo: https://t.co/g0uwFdtR2s

[Therabron @Therabron]

CEO Tom Miller to present at the BioCentury 23rd Annual Future Leaders in the #Biotech Industry Conf on 3/11 in NYC https://t.co/D7QhLLPDtd

[Therabron @Therabron]

Company presents today at the 2016 #Biotech Showcase Conference at 8:45am PDT in San Fran #pharma https://t.co/19iXyYtMJB

[Therabron @Therabron]

Company to present at the 2016 #Biotech Showcase Conference on 1/12 at 8:45am PDT in San Fran #pharma #vc https://t.co/qw3GHpiDHO

[Therabron @Therabron]

(3/3) Company hires Anita Fauchier as Vice President of Regulatory Affairs and Quality Assurance #biotech #pharma https://t.co/pvNIKJVnrg